Valrubicin - Valderm

Drug Profile

Valrubicin - Valderm

Alternative Names: Topical valrubicin; Valrubicin cream

Latest Information Update: 26 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Valderm
  • Class Anthracyclines; Antineoplastics; Cytostatics; Small molecules
  • Mechanism of Action DNA intercalators; DNA repair enzyme inhibitors; Type II bacterial DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Plaque psoriasis

Most Recent Events

  • 26 Aug 2015 Discontinued - Phase-II for Plaque psoriasis in Germany (Topical)
  • 17 Sep 2011 Valderm completes its phase IIa trial for Plaque psoriasis in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top